| |
| |
|
| Insider
Information: |
Xanthopoulos Kleanthis G |
| Relationship: |
Director |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
122,200 |
|
|
Indirect Shares
|
281,935 |
|
|
| Direct
Value |
$19,622 |
|
|
|
Indirect Value
|
$164,649 |
|
|
| Total
Shares |
404,135 |
|
|
| Total
Value |
$184,270 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Anadys Pharmaceuticals Inc |
ANDS |
Director |
2007-08-16 |
7,399 |
2007-08-16 |
177,144 |
Premium* |
|
|
Seelos Therapeutics Inc |
SEEL |
Director |
2012-08-15 |
87,500 |
2017-01-05 |
24,575 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
President and CEO, Dir... |
2015-04-21 |
3,705 |
2015-04-21 |
80,216 |
Premium* |
|
|
Zosano Pharma Corp |
ZSAN |
Director |
2021-06-10 |
23,596 |
2015-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
89 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ANDS |
Anadys Pharmaceuticals In... |
CEO and PresidentOfficer |
• • – |
2004-03-18 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
244,885 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
CEO and President |
• • – |
2005-06-21 |
4 |
AS |
$8.22 |
$43,606 |
I/I |
(5,000) |
233,744 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
CEO and President |
• • – |
2005-07-18 |
4 |
AS |
$11.18 |
$56,243 |
I/I |
(5,000) |
228,744 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
CEO and President |
• • – |
2005-08-15 |
4 |
AS |
$12.67 |
$64,274 |
I/I |
(5,000) |
223,744 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
CEO and President |
• • – |
2005-09-19 |
4 |
AS |
$13.17 |
$66,506 |
I/I |
(5,000) |
218,744 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
CEO and President |
• • – |
2005-10-17 |
4 |
AS |
$10.73 |
$54,660 |
I/I |
(5,000) |
213,744 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
CEO and President |
• • – |
2005-11-21 |
4 |
AS |
$10.41 |
$52,990 |
I/I |
(5,000) |
208,744 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
officerTitle |
• • – |
2005-12-19 |
4 |
AS |
$8.02 |
$40,556 |
I/I |
(5,000) |
203,744 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
officerTitle |
• • – |
2006-01-17 |
4 |
AS |
$10.96 |
$54,953 |
I/I |
(5,000) |
198,744 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
CEO and President |
• • – |
2006-02-21 |
4 |
AS |
$11.55 |
$59,027 |
I/I |
(5,000) |
193,744 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
CEO and President |
• • – |
2006-02-28 |
4 |
S |
$12.99 |
$79,753 |
I/I |
(6,141) |
0 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
CEO and President |
• • – |
2006-03-07 |
4 |
S |
$14.60 |
$440,891 |
D/D |
(30,000) |
5,453 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
CEO and President |
• • – |
2006-03-07 |
4 |
OE |
$2.95 |
$88,500 |
D/D |
30,000 |
35,453 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
CEO and President |
• • – |
2006-03-20 |
4 |
AS |
$15.19 |
$76,654 |
I/I |
(5,000) |
188,744 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
CEO and President |
• • – |
2006-04-17 |
4 |
AS |
$14.76 |
$74,280 |
I/I |
(5,000) |
183,744 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
CEO and President |
• • – |
2006-05-15 |
4 |
AS |
$10.45 |
$52,514 |
I/I |
(5,000) |
178,744 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
CEO and President |
• • – |
2006-06-19 |
4 |
AS |
$6.97 |
$20,991 |
I/I |
(3,000) |
175,744 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
CEO and President |
• • – |
2006-06-19 |
4 |
AS |
$7.00 |
$42,007 |
D/D |
(6,000) |
6,389 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
CEO and President |
• • – |
2006-06-19 |
4 |
OE |
$2.95 |
$17,700 |
D/D |
6,000 |
12,389 |
|
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
CEO and President |
• • – |
2006-11-14 |
4 |
AS |
$5.00 |
$500 |
I/I |
(100) |
175,644 |
0 |
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
Director |
– • – |
2007-02-05 |
4 |
GD |
$0.00 |
$0 |
I/I |
5,000 |
170,644 |
0 |
- |
|
| ANDS |
Anadys Pharmaceuticals In... |
Director |
– • – |
2007-08-16 |
4 |
B |
$2.15 |
$13,957 |
I/I |
6,500 |
177,144 |
2.1 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President & CEOOfficer |
• • – |
2012-10-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
82,216 |
|
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President & CEO |
• • – |
2013-12-16 |
4 |
GD |
$0.00 |
$0 |
I/I |
2,000 |
80,216 |
0 |
- |
|
| RGLS |
Regulus Therapeutics Inc. |
President & CEO |
• • – |
2014-01-02 |
4 |
AS |
$7.25 |
$25,408 |
I/I |
(3,505) |
80,216 |
0 |
- |
|
89 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
